Athanasios Tsiatis

Director Técnico/Científico/I+D en ALX ONCOLOGY HOLDINGS INC. .

Consumer Services

Commercial Services

Health Technology

Perfil

Athanasios Tsiatis currently works at ALX Oncology Holdings, Inc., as Senior Vice President-Clinical Development from 2021.
Dr. Tsiatis also formerly worked at Plexxikon, Inc., as Vice President-Clinical Development from 2020 to 2021.
Dr. Tsiatis received his undergraduate degree from New York University and doctorate degree from Vanderbilt University School of Medicine.

Cargos activos de Athanasios Tsiatis

Empresas	Cargo	Inicio
ALX ONCOLOGY HOLDINGS INC.	Director Técnico/Científico/I+D	01/11/2021

Todos los cargos activos de Athanasios Tsiatis

Antiguos cargos conocidos de Athanasios Tsiatis.

Empresas	Cargo	Fin
Plexxikon, Inc. Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services	Director Técnico/Científico/I+D	01/11/2021

Ver el detalle de la experiencia de Athanasios Tsiatis.

Formación de Athanasios Tsiatis.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Athanasios Tsiatis.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Plexxikon, Inc. Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services	Commercial Services
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vanderbilt University School of Medicine Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ALX Oncology Holdings, Inc. ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer	Health Technology